MDCE
Global CRO
A Global Clinical Trial CRO Supporting the International Expansion of MedTech Companies Worldwide.
Accelerating Global Expansion for MedTech Innovations!
Discover how MDCE can help MedTech companies accelerate their global market entry
MDCE conducts clinical research in over 30 countries, supporting a wide range of therapeutic areas and offering tailored solutions for global MedTech companies. With extensive expertise in global regulatory landscapes and market entry strategies, we help companies accelerate international expansion, reducing time-to-market and costs. Our goal is to seamlessly connect innovations with international patients, ensuring successful global market entry.

Solutions & Services Core Services

Global Clinical Trials
Expert guidance throughout the global clinical trial process, ensuring compliance with international regulations and maximizing efficiency for successful market approval.

Regulatory Affairs
Streamlined regulatory support to navigate market entry requirements, from product classification to submission, ensuring compliance across global regions.

Business Consulting
Tailored consulting services, including market research, product pricing strategies, and healthcare policy advisory, helping sponsors reduce risk and accelerate international growth.
Our Achievements




Core Advantage
.jpg?width=1920&height=741&name=R-C%20(3).jpg)
Comprehensive Therapeutic Areas
MDCE has rich resources and project experience to meet different sponsor needs.
Involving fields——
- Cardiovascular
- Electrophysiology
- Neurology
- Neurosurgery
- Endocrinology
- Oncology
- Rare disease
- Vaccine
- Cosmetic medicine
- Ophthalmology
- Gene therapy
- Pulmonary diseases
- Infectious diseases
- Hepatology
- Hematology
- Central Nervous System
- Respiratory diseases
- Metabolism
- Gynecology
- Orthopedics
- Psychiatry
- ... ...

Government relations
MDCE has forged strong relationships with governments and regulatory bodies worldwide, ensuring smooth market entry and efficient project execution.
Building Local Partnerships——
Europe (10+)
- United Kingdom
- Germany
- France
- Italy
- Poland
- Bulgaria
- Latvia
- ... ...
North America (8+)
- United States
- Canada
- Mexico
- ... ...
Asia-Pacific (10+)
- Australia
- Singapore
- Thailand
- Indonesia
- Saudi Arabia
- ... ...

Partnership Institutions
MDCE partners with leading institutions worldwide to ensure global trial success.
Regions Covered——
Europe (20+)
- Germany Heart Center Berlin
- Poland Cardinal Wyszynski National Institute of Cardiology
- United Kingdom University of Birmingham Enterprise Ltd
- ... ...
North America (10+)
- Wilmer Eye Institute, Johns Hopkins Hospital
- Myopia Control Clinic, University of California, Berkeley
- New England College of Optometry
- ... ...
Asia-Pacific (20+)
- Singapore Mount Elizabeth Medical Centre
- Hong Kong The Chinese University of Hong Kong
- Thailand Faculty of Medicine, Chiang Mai University
- ... ...

Rich Project experience
Having rich overseas clinical project experience——
Europe (35+):
Successfully managed highly complex clinical projects, including
- Gastric bypass stent
- Coronary bioresorbable scaffolds
- Artificial blood vessels
- ... ...
United States (20+):
Delivered groundbreaking clinical and regulatory achievements for cutting-edge medical devices, including
- Aortic dissection total endovascular reconstruction system
- Interventional artificial heart
- Ischemic stroke CT imaging evaluation software
- .. ...
Asia-Pacific(20+):
Enabled successful market entry and clinical trials for innovative devices, including
- Distal access catheters
- Intracranial aspiration catheters
- Hydrophilic contact lenses
- ... ...